Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda Massmann

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 8, 2023
Impact of transitioning to an active, noninterruptive CYP2C19/proton pump inhibitor alert on prescribing patternsAmanda Massmann, Natasha J Petry
Pharmacogenomics|July 12, 2023
Congruence rates for pharmacogenomic noninterruptive alertsSarah C Mills, Amanda Massmann
Pharmacotherapy|December 1, 2025
Developing a Statistical Modeling-Based Machine Learning Approach for Capturing Drug Dosing Using a Proton Pump Inhibitor CaseAmanda Massmann, Jordan F Baye, Max Weaver
Journal of the American Pharmacists Association : Japha|August 15, 2025
Evaluation of the Impact of CYP2D6 Testing on Outcomes in Patients Taking OpioidsHalle Brady, Max Weaver, Jordan Baye, et al.
Pharmacogenomics|December 1, 2022
Leveraging clinical decision support to reduce the risk of discordant pharmacogenomics resultsAmanda Massmann, Joel Van Heukelom, Chad Larson, et al.
Annals of Translational Medicine|January 9, 2023
The effect of medication reconciliation on generating an accurate medication list in a pharmacogenomics practiceNatasha J Petry, Joel Van Heukelom, Jordan F Baye, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 9, 2025
Aripiprazole and CYP2D6: A retrospective cohort study evaluating the impact of CYP2D6 phenotype on metabolic abnormalitiesBrian R Meissner, Fatme Younes, Amanda Massmann, et al.
Clinical and Translational Science|March 9, 2026
Clinician Satisfaction With Pharmacogenomics Clinical Services at a Multistate Health SystemKristen Jacobsen, Natasha J Petry, Max Weaver, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 16, 2024
Impact of using dosing criteria to refine pharmacogenomic clinical decision support for tricyclic antidepressantsAmanda Massmann, Natasha Petry, Sarah Mills, et al.
JAMIA Open|October 6, 2025
Analyzing the impact of pharmacogenomics-guided nonsteroidal anti-inflammatory drug alerts in clinical practiceAmanda Massmann, Natasha J Petry, Max Weaver, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 8, 2023
Impact of transitioning to an active, noninterruptive CYP2C19/proton pump inhibitor alert on prescribing patternsAmanda Massmann, Natasha J Petry
Pharmacogenomics|July 12, 2023
Congruence rates for pharmacogenomic noninterruptive alertsSarah C Mills, Amanda Massmann
Pharmacotherapy|December 1, 2025
Developing a Statistical Modeling-Based Machine Learning Approach for Capturing Drug Dosing Using a Proton Pump Inhibitor CaseAmanda Massmann, Jordan F Baye, Max Weaver
Journal of the American Pharmacists Association : Japha|August 15, 2025
Evaluation of the Impact of CYP2D6 Testing on Outcomes in Patients Taking OpioidsHalle Brady, Max Weaver, Jordan Baye, et al.
Pharmacogenomics|December 1, 2022
Leveraging clinical decision support to reduce the risk of discordant pharmacogenomics resultsAmanda Massmann, Joel Van Heukelom, Chad Larson, et al.
Annals of Translational Medicine|January 9, 2023
The effect of medication reconciliation on generating an accurate medication list in a pharmacogenomics practiceNatasha J Petry, Joel Van Heukelom, Jordan F Baye, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 9, 2025
Aripiprazole and CYP2D6: A retrospective cohort study evaluating the impact of CYP2D6 phenotype on metabolic abnormalitiesBrian R Meissner, Fatme Younes, Amanda Massmann, et al.
Clinical and Translational Science|March 9, 2026
Clinician Satisfaction With Pharmacogenomics Clinical Services at a Multistate Health SystemKristen Jacobsen, Natasha J Petry, Max Weaver, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 16, 2024
Impact of using dosing criteria to refine pharmacogenomic clinical decision support for tricyclic antidepressantsAmanda Massmann, Natasha Petry, Sarah Mills, et al.
JAMIA Open|October 6, 2025
Analyzing the impact of pharmacogenomics-guided nonsteroidal anti-inflammatory drug alerts in clinical practiceAmanda Massmann, Natasha J Petry, Max Weaver, et al.
Pageof 3